They attempted to grow the mouse mammary carcinoma (MMC) cell line, originally derived from HER2 transgenic mice, in Friend leukaemia virus 1b (FVB/N) parental mice and found after some time that a more resilient immuno-edited population arose, which was determined to have gained a mesenchymal phenotype. The gene discussed is ERBB2; the disease is breast carcinoma.